The new dengue vaccine will be available in Brazil from next week. A Kdengafrom the Takeda laboratory, was approved by Anvisa in March and is the first vaccine to protect against all serotypes.

Vaccine first protects against all serotypes – Credit: Joinville City Hall/Disclosure/ND

According to the ABCVAC (Brazilian Association of Vaccine Clinics), the dose will be available in a private network and should cost between 350 and 500 reais at the discretion of the state. For example, in São Paulo, the maximum price approved by the CMED (Medicine Regulatory Chamber) was R$ 379.40.

In clinical studies, Qdenga has shown 80% protection. Unlike the only immunizer currently available, Dengvaxia, it can be given to those who have not yet had the disease.

The immunizer was released for individuals aged 4 to 60 years. The vaccination schedule includes two subcutaneous doses with an interval between them of three months.

Dengue in Brazil

It is endemic in Brazil, with about 1,000 deaths last year and more than 1.4 million likely cases. This year, the numbers continue to rise.

From January to June, the Ministry of Health has already recorded the same number of cases as last year, in addition to 709 deaths. In Santa Catarina, the number of deaths caused by the disease has reached 67.